45 results
8-K
IMPL
Impel Pharmaceuticals Inc
4 Oct 23
Entry into a Material Definitive Agreement
5:21pm
achievement of certain strategic milestones, satisfaction of minimum net revenue and product units sold covenants and satisfaction of certain other covenants
8-K
IMPL
Impel Pharmaceuticals Inc
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
process milestones, satisfaction of minimum net revenue and product units sold covenants sand satisfaction of certain other covenants and conditions
8-K
EX-10.1
IMPL
Impel Pharmaceuticals Inc
4 Oct 23
Entry into a Material Definitive Agreement
5:21pm
defined herein shall have the meanings assigned to such terms in the Existing Credit Agreement.
2.Amendments. Subject to the satisfaction … in principal amount of Tranche B Term Loans upon satisfaction of the Milestone required to be completed by October 6, 2023 (subject to satisfaction of all
8-K
EX-99.2
IMPL
Impel Pharmaceuticals Inc
18 Jan 22
Impel NeuroPharma Provides Updates on TrudhesaTM Launch
8:01am
: Physician Satisfaction Trudhesa Reyvow Ubrelvy Nurtec ODT (acute) Aided and Unaided Awareness Trudhesa experience leads to high satisfaction levels
S-1/A
EX-10.4
IMPL
Impel Pharmaceuticals Inc
19 Apr 21
IPO registration (amended)
6:10am
be, but need not be, awarded upon satisfaction of such Performance Factors during any Performance Period as are set out in advance in the Participant’s … individual Award Agreement. If the Option is being earned upon the satisfaction of Performance Factors, then the Committee will: (a) determine the nature
S-1
EX-10.10
4tlozeo 2j92
2 Apr 21
IPO registration
3:04pm
8-K
EX-10.1
nkyex yyp7
20 Dec 23
Impel Pharmaceuticals Announces Filing Voluntary Chapter 11 Cases and Signing of “Stalking Horse” Agreement to Facilitate Sale
6:08am
S-3
EX-4.4
cc1rota12f3er
16 May 22
Shelf registration
4:49pm
8-K
EX-10.1
81ewiodw0s 15isg9
21 Aug 23
Entry into a Material Definitive Agreement
8:33am
8-K
EX-10.1
4iba1 a2tdgyqssik
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
S-1
EX-3.1
uxji s2x4omoimt
2 Apr 21
IPO registration
3:04pm
S-1/A
EX-3.1
i7dmn
19 Apr 21
IPO registration (amended)
6:10am
8-K
EX-10.3
pzz6m403ff2i6l4kb
7 Sep 23
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.1
bw21 uqny7zwpm
14 Nov 23
Departure of Directors or Certain Officers
4:01pm
S-1
EX-10.3
44hzsvd4v3j
2 Apr 21
IPO registration
3:04pm
424B5
mswqa 30htod1iyauv
5 Oct 23
Prospectus supplement for primary offering
5:19pm
S-1
EX-10.9
inm47jg 94
2 Apr 21
IPO registration
3:04pm